Literature DB >> 9781639

Paragangliomas of the head and neck region show complete loss of heterozygosity at 11q22-q23 in chief cells and the flow-sorted DNA aneuploid fraction.

E M van Schothorst1, M Beekman, P Torremans, N J Kuipers-Dijkshoorn, H W Wessels, A F Bardoel, A G van der Mey, M J van der Vijver, G J van Ommen, P Devilee, C J Cornelisse.   

Abstract

Nonchromaffin paragangliomas of the head and neck region, also known as glomus tumors, are usually benign neoplasms consisting of clusters of chief cells surrounded by sustentacular cells arranged in so-called 'Zellballen.' Most of the patients have a familial background. In a previous study, examining all chromosome arms, we found loss of heterozygosity (LOH) predominantly at the chromosome 11q22-q23 region, where the disease causing gene PGL1 has been located by linkage analysis. However, all tumors showed only partial loss of allele signal intensities, and it was not clear whether this represented allelic imbalance or cellular heterogeneity. In the current study, we have performed LOH analysis for the 11q22-q23 region on DNA-aneuploid tumor cells, enriched by flow sorting, and on purified chief cell fractions obtained by single-cell microdissection. Complete LOH was found for two markers (D11S560 and CD3D) in the flow-sorted aneuploid fractions, whereas no LOH was found in the diploid fractions of three tumors. The microdissected chief cells from two of these tumors also showed complete LOH for both markers, indicating that the chief cells are clonal proliferated tumor cells. These results indicate that the PGL1 gene is likely to be a tumor suppressor gene, which is inactivated according to the two-hit model of Knudson. Furthermore, it shows that chief cells are a major if not the sole neoplastic component of paragangliomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9781639     DOI: 10.1016/s0046-8177(98)90411-7

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  Cervical paragangliomas: neurovascular surgical risk and therapeutic management.

Authors:  J Paris; F Facon; J M Thomassin; M Zanaret
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-07-06       Impact factor: 2.503

Review 2.  Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.

Authors:  Hilde Dannenberg; Paul Komminoth; Winand N M Dinjens; Ernst Jan M Speel; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 3.  The power of yeast to model diseases of the powerhouse of the cell.

Authors:  Matthew G Baile; Steven M Claypool
Journal:  Front Biosci (Landmark Ed)       Date:  2013-01-01

4.  Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.

Authors:  Attje S Hoekstra; Marieke A de Graaff; Inge H Briaire-de Bruijn; Cor Ras; Reza Maleki Seifar; Ivonne van Minderhout; Cees J Cornelisse; Pancras C W Hogendoorn; Martijn H Breuning; Johnny Suijker; Esther Korpershoek; Henricus P M Kunst; Norma Frizzell; Peter Devilee; Jean-Pierre Bayley; Judith V M G Bovée
Journal:  Oncotarget       Date:  2015-11-17

5.  Incomplete penetrance of a novel SDHD variation causing familial head and neck paraganglioma.

Authors:  Martin Koenighofer; Thomas Parzefall; Alexandra Frohne; Elisabeth Frei; Christian Schoefer; Franco Laccone; Patricia Feil; Klemens Frei; Trevor Lucas
Journal:  Clin Otolaryngol       Date:  2021-05-05       Impact factor: 2.597

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.